María Arestin

619 total citations
14 papers, 425 citations indexed

About

María Arestin is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, María Arestin has authored 14 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in María Arestin's work include Renal cell carcinoma treatment (5 papers), Renal and related cancers (5 papers) and Cancer Genomics and Diagnostics (4 papers). María Arestin is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Renal and related cancers (5 papers) and Cancer Genomics and Diagnostics (4 papers). María Arestin collaborates with scholars based in Spain, United Kingdom and Czechia. María Arestin's co-authors include Charles H. Lawrie, Lorea Manterola, María Armesto, Ibai Goicoechea, Marta Fernández‐Mercado, Erika Larrea, Carla Solé, María M. Caffarel, Angela M. Araujo and David Otaegui and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and The Journal of Pathology.

In The Last Decade

María Arestin

14 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
María Arestin Spain 9 321 263 86 51 36 14 425
Kazuki Heishima Japan 13 287 0.9× 222 0.8× 116 1.3× 65 1.3× 21 0.6× 36 453
Ibai Goicoechea Spain 8 330 1.0× 266 1.0× 75 0.9× 68 1.3× 16 0.4× 14 430
Yuanlin Wu China 11 281 0.9× 181 0.7× 77 0.9× 118 2.3× 21 0.6× 24 469
Dali Yan China 12 390 1.2× 345 1.3× 44 0.5× 99 1.9× 21 0.6× 14 503
Erika Larrea Spain 6 283 0.9× 259 1.0× 64 0.7× 34 0.7× 18 0.5× 8 362
Cristina Borzi Italy 12 275 0.9× 242 0.9× 63 0.7× 94 1.8× 23 0.6× 18 413
Nan Huo China 8 190 0.6× 126 0.5× 47 0.5× 76 1.5× 17 0.5× 8 302
Alejandro Villar‐Prados United States 7 278 0.9× 169 0.6× 23 0.3× 52 1.0× 23 0.6× 12 374
Sheeba Jacob India 11 169 0.5× 97 0.4× 123 1.4× 71 1.4× 12 0.3× 29 344

Countries citing papers authored by María Arestin

Since Specialization
Citations

This map shows the geographic impact of María Arestin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Arestin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Arestin more than expected).

Fields of papers citing papers by María Arestin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Arestin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Arestin. The network helps show where María Arestin may publish in the future.

Co-authorship network of co-authors of María Arestin

This figure shows the co-authorship network connecting the top 25 collaborators of María Arestin. A scholar is included among the top collaborators of María Arestin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Arestin. María Arestin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Armesto, María, María Arestin, Manuel Manrique, et al.. (2024). Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients. International Journal of Molecular Sciences. 25(13). 6881–6881. 1 indexed citations
2.
Armesto, María, María Arestin, Claudia Manini, et al.. (2024). Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms. Pathology. 56(4). 493–503. 3 indexed citations
3.
Armesto, María, María Arestin, Peio Errarte, et al.. (2021). Integrated mRNA and miRNA Transcriptomic Analyses Reveals Divergent Mechanisms of Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (ccRCC). Cancers. 13(17). 4401–4401. 8 indexed citations
4.
Solé, Carla, Ibai Goicoechea, María Armesto, et al.. (2020). The Urinary Transcriptome as a Source of Biomarkers for Prostate Cancer. Cancers. 12(2). 513–513. 17 indexed citations
5.
Lawrie, Charles H., María Armesto, Marta Fernández‐Mercado, et al.. (2017). Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms. Journal of Molecular Diagnostics. 20(1). 34–45. 18 indexed citations
6.
Ch’ng, Ewe Seng, Charles H. Lawrie, María Arestin, et al.. (2017). DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas. Pathology. 49(7). 731–739. 22 indexed citations
7.
Larrea, Erika, Carla Solé, Lorea Manterola, et al.. (2016). New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies. International Journal of Molecular Sciences. 17(5). 627–627. 193 indexed citations
8.
Solé, Carla, Erika Larrea, Lorea Manterola, et al.. (2016). Aberrant Expression of MicroRNAs in B-cell Lymphomas. MicroRNA. 5(2). 87–105. 6 indexed citations
9.
Wong, Kah Keng, Ewe Seng Ch’ng, Azlan Husin, et al.. (2015). Low HIP1R mRNA and protein expression are associated with worse survival in diffuse large B-cell lymphoma patients treated with R-CHOP. Experimental and Molecular Pathology. 99(3). 537–545. 13 indexed citations
10.
Fernández‐Mercado, Marta, Lorea Manterola, Erika Larrea, et al.. (2015). The circulating transcriptome as a source of non‐invasive cancer biomarkers: concepts and controversies of non‐coding and codingRNAin body fluids. Journal of Cellular and Molecular Medicine. 19(10). 2307–2323. 64 indexed citations
11.
Álvarez, Isabel, Ricardo Rezola, Irune Ruiz, et al.. (2015). Hormone receptors and HER2 expression in primary tumor and synchronous axillary lymph node metastasis in estrogen receptor positive breast cancer.. Journal of Clinical Oncology. 33(15_suppl). e11580–e11580. 1 indexed citations
12.
Lawrie, Charles H., Erika Larrea, Gorka Larrinaga, et al.. (2013). Targeted next‐generation sequencing and non‐coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes. The Journal of Pathology. 232(1). 32–42. 44 indexed citations
13.
Ballabio, Erica, María Armesto, Lorea Manterola, et al.. (2012). Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?. Blood Cancer Journal. 2(8). e83–e83. 27 indexed citations
14.
Arestin, María, Javier Ramón‐Azcón, Begoña Alfaro, et al.. (2010). Evaluation of Immunoassays as an Alternative for the Rapid Determination of Pesticides in Wine and Grape Samples. Journal of AOAC International. 93(1). 2–11. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026